Clinical research involves more people than a single coordinator and a single investigator. A multi-site trial may involve dozens of sites, each with their own teams, their own institutional contexts, and their own pressures. Communication across that structure is not incidental to research quality — it is one of the primary mechanisms through which research quality is either maintained or lost.
Who Is Communicating With Whom
At a research site, the communication network is more complex than it appears from the outside. The research team communicates with participants — recruiting, screening, consenting, following up. The team communicates with the principal investigator, who is responsible for the conduct of the trial at the site but may not be present for every visit. The team communicates with monitors and clinical research associates, who verify that the data recorded at the site matches the source documents. The team communicates with the sponsor, who holds the IND and is ultimately responsible for the overall trial. And it communicates with the IRB, which reviews the protocol and any protocol modifications or adverse events that meet reporting thresholds.
Each of those communication channels has its own norms, its own urgency signals, and its own consequences for delay or imprecision. A protocol deviation that is communicated to the sponsor promptly can be assessed and managed. The same deviation communicated three weeks later, or communicated imprecisely, creates a quality issue that is harder to address after the fact.
Clarity Across Levels of Technical Background
One of the specific challenges in clinical research communication is that the people involved have very different levels of technical background. A sponsor’s medical monitor may have a deep understanding of the therapeutic area. A participant may have no background in clinical science at all. A site principal investigator may understand the science but not the regulatory details. A contract research organization project manager may understand the regulatory details but not the clinical nuances of a particular patient population.
Communicating effectively across those different backgrounds requires the ability to adjust register without losing accuracy. Explaining an adverse event to a medical monitor is different from explaining a study visit to a participant, which is different from briefing an investigator on a protocol question. The underlying information is the same. The framing changes depending on what the listener needs to understand and what decisions they need to make.
What Justin Coffeen’s Background Contributes
Justin Coffeen’s path to clinical research included years of clinical practice, three years in years of teaching graduate-level health sciences, and three years of military service. Each of those contexts involved communication across different roles and different levels of expertise. In clinical practice, the communication challenge is patient-facing: explaining a diagnosis or a treatment plan to someone who may be anxious or in pain. In a classroom, it is instructional: building a technical concept clearly for students who will need to apply it. In a military medical unit, it is procedural: following and enforcing communication protocols under conditions where clarity directly affects outcomes.
None of these backgrounds is sufficient on its own to produce an effective research communicator. Together, they provide a range of communication experiences that applies well to the multi-party environment of clinical research.
The Cost of Communication Failures in Research
Poor communication in research has real costs. Participants who do not understand what they are consenting to may withdraw at higher rates or may not report symptoms they think are irrelevant. Investigators who are not briefed promptly on protocol amendments may conduct visits out of compliance. Sponsors who receive unclear or delayed reports from sites may lose confidence in the site’s data, which can affect future trials and study relationships.
The attention that experienced research professionals give to clear, timely communication is not about formality. It is about keeping the research enterprise functioning in a way that produces reliable data and treats participants well — which are, ultimately, the same goal.
Read more about moving across therapeutic areas in clinical research, or about what GCP compliance looks like day to day. Learn more about Justin Coffeen.